Technical Articles

GPRC5D
GPRC5D靶点赛道全解析： 双抗、CAR-T、三抗同台竞技
Comprehensive Analysis of the GPRC5D Target Arena: Bispecific Antibodies, CAR-T, and Trispecific Antibodies Compete on the Same Stage
发布时间 2026-08-11
Multiple Myeloma (MM) is the second most common malignant tumor in the hematopoietic system. Despite continuous advancements in existing treatments, the majority of patients will ultimately face the challenges of relapse or drug resistance.
View details
  • Cancer
  • GPRC5D
Total 1
  • 1
Go to
UA
Link：
Products
Application
Cell FactorTarget Proteins
Custom Services
Custom Protein Expression ServicesCustom SPR Services
About Us
PromotionTechnical ArticlesProduct ApplicationFAQsCitationsAbout Us
We Media：
Facebook Linkedin YouTube X Thraeds Pinterest
©2021-2026 all rights reserved UA Biotechnology Co.,Ltd.
Privacy Policy
网站备案号 浙ICP备2022019033号-2 浙公网安备33010202004867号
 Business license (three certificates in one)
Tel：+86-25-56221161
E-mail：order@ua-bio.com
All products sold on this website shall not be used for clinical diagnosis or treatment of humans or animals, and shall only be used for non-medical purposes such as industrial or scientific research.